The Johnson & Johnson logo is prominently displayed at company offices on October 17, 2023 in Irvine, California. (Photo by Mario Tama/Getty Images)
OAN Staff James Meyers 9:14 AM – Friday, March 21, 2025
The Trump administration revealed a substantial investment initiative from a leading pharmaceutical firm on Friday.
Advertisement
According to the pharmaceutical giant, Johnson & Johnson is set to invest $55 billion in the U.S. over the next four years, focusing on manufacturing, research, and technological advancements.
Johnson & Johnson announces a new $55 billion investment in the U.S. over the next four years for manufacturing, research and development, and technology.
According to Johnson & Johnson, this investment signifies a “25% increase compared to the prior four years,” building upon the elevated U.S. investment levels following the 2017 Tax Cuts & Jobs Act, which was enacted during President Donald Trump’s tenure.
“Our increased investment in the U.S. commences with the groundbreaking of a cutting-edge facility in North Carolina, aimed at creating U.S.-based jobs and manufacturing advanced medicines for patients both domestically and globally,” stated Chairman and CEO Joaquin Duato.
This significant announcement arrives after several commitments from major American corporations, totaling nearly $1 trillion thus far, to expand manufacturing within the United States, reinforcing a key objective of President Trump’s trade policies.
The company clarified that the $55 billion investment plan reflects a 25% increase over the last four years.
The investment encompasses the construction of three new facilities at yet-to-be-disclosed locations and the expansion of existing sites. Additionally, it will facilitate research in medication and robotics, alongside investments in technology aimed at accelerating drug discovery.
“Our investment in the U.S. includes breaking ground on a high-tech facility in North Carolina that will generate jobs at home while producing innovative medicines to cater to patients in the U.S. and around the world,” CEO Joaquin Duato remarked in a statement.
In a related development, Johnson & Johnson’s competitor, Eli Lilly and Co., revealed plans in late February to establish four new factories within the country.
Furthermore, in February, Apple disclosed a $500 billion investment strategy in the U.S. over the next four years, which includes the intention to recruit at least 20,000 personnel and construct a new server factory in Texas.
Stay updated! Get breaking news alerts directly to your inbox for free. Subscribe here. https://www.oann.com/alerts
